Latest vomiting Stories

Prescription Treatment Now Available in Pharmacies for Nearly Three Million Pregnant Women Who Suffer From NVP ROSEMONT, Pa., May 21, 2013 /PRNewswire/ -- Duchesnay USA, the first pharmaceutical company dedicated to the health of pregnant women, announces the U.S. market introduction of Diclegis(®) (doxylamine succinate 10mg and pyridoxine hydrochloride -vitamin B(6)- 10mg), now available in pharmacies across the country. Diclegis was recently approved by the U.S. Food and Drug...

Data to Be Presented at Annual Meeting of the American Society of Clinical Oncology (ASCO) LUGANO, Switzerland and WOODCLIFF LAKE, N.J., May 16, 2013 /PRNewswire/ -- Helsinn Group and Eisai Inc. announced today top-line results from Helsinn's pivotal clinical studies investigating the oral fixed-dose combination of netupitant and palonosetron (NEPA) being evaluated for the proposed indication of prevention of chemotherapy-induced nausea and vomiting (CINV). These data will be...

Campaign advocates need for education and action for mothers and babies affected by Hyperemesis Gravidarum (HG), a frequently misdiagnosed pregnancy disease WASHINGTON, May 9, 2013 /PRNewswire/ -- Recently put in international spotlight by the hospitalization of mom-to-be Kate Middleton, Duchess of Cambridge, pregnancy disease Hyperemesis Gravidarum (HG) is the focus of HG Awareness Day on May 15. Sponsored by the HER Foundation (www.helpher.org), HG Awareness Day will bring...

Majority of Pregnant Women Say Their Lives are Significantly Affected by NVP ROSEMONT, Pa., May 8, 2013 /PRNewswire/ -- A new survey released today finds that the term "morning sickness" may not be doing the condition justice as eight in 10 women suffering from nausea and vomiting of pregnancy (NVP) experience it for 2-6 hours per day, often in the afternoon or evening. NVP, also known as morning sickness, is the most common pregnancy symptom, affecting 70 to 85 percent of pregnant...

CHARLESTON, S.C., April 16, 2013 /PRNewswire/ -- Charleston Laboratories, Inc, an emerging specialty pharmaceutical company focused on the research and development of novel pain products that prevent or significantly reduce nausea and vomiting related to opioid analgesics and other pain associated disease states, announced today the U.S. Food and Drug Administration has granted its request for a Pre-IND meeting to discuss the proposed Investigational New Drug, CL-H1T, as a novel...

redOrbit Staff & Wire Reports - Your Universe Online A drug pulled from pharmacies three decades ago following accusations that it was responsible for causing birth defects has now become the only US Food and Drug Administration (FDA)-approved treatment for morning sickness, according to various media reports published Tuesday. The medication is known as Diclegis, and according to MedPageToday Staff Writer Nancy Walsh it is a combination of vitamin B6 and an antihistamine. More...

More than 1 million kids get sick from norovirus each year. Teaching children basic sanitation and using simple precautions at home can protect them from this dangerous stomach virus. Austin, TX (PRWEB) April 09, 2013 Norovirus sends more than one million children under age five to the doctor each year. Texas Pediatrician Dr. Marta Katalenas, advises parents to establish a regular routine of sanitary precautions that can dramatically reduce the risk of infection from norovirus. According...

BLAINVILLE, QC, April 9, 2013 /CNW Telbec/ - Following the US approval of its morning sickness medication Diclegis by the US Food and Drug Administration (FDA), the Canadian pharmaceutical company Duchesnay Inc. is proud to announce that this approval sets the obstetric medicine specialty company for international expansion. Diclegis has been available in Canada under the trade name Diclectin® for more than 30 years as the only prescription drug specifically indicated and...

In the news release, FDA Approves Duchesnay USA's Diclegis® for Treatment of Nausea and Vomiting of Pregnancy (NVP), issued 08-Apr-2013 by Duchesnay USA over PR Newswire, we are advised by the company that Laney Cohen's phone number should read "(212) 508-9643" rather than "(215) 508-9643" as originally issued inadvertently. The complete, corrected release follows: FDA Approves Duchesnay USA's Diclegis® for Treatment of Nausea and Vomiting of Pregnancy (NVP) Diclegis becomes only...

Diclegis becomes only FDA-approved treatment for "morning sickness" in decades ROSEMONT, Pa., April 8, 2013 /PRNewswire/ -- Duchesnay USA today announced that the Food and Drug Administration (FDA) has granted approval for Diclegis(®) (doxylamine succinate 10mg, pyridoxine hydrochloride 10mg) delayed-release tablets for the treatment of nausea and vomiting of pregnancy (NVP) in women who do not respond to conservative management.(i) It is the only FDA-approved treatment for NVP,...